Macquarie Group Ltd. boosted its holdings in Cooper Companies Inc (NYSE:COO) by 21.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,410 shares of the medical device company’s stock after buying an additional 2,675 shares during the period. Macquarie Group Ltd.’s holdings in Cooper Companies were worth $3,629,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Archford Capital Strategies LLC acquired a new stake in shares of Cooper Companies during the 1st quarter worth approximately $156,000. GWM Advisors LLC acquired a new stake in shares of Cooper Companies during the 2nd quarter worth approximately $200,000. First Allied Advisory Services Inc. acquired a new stake in shares of Cooper Companies during the 1st quarter worth approximately $200,000. IFM Investors Pty Ltd acquired a new stake in shares of Cooper Companies during the 1st quarter worth approximately $208,000. Finally, IFP Advisors Inc grew its holdings in shares of Cooper Companies by 94.0% during the 1st quarter. IFP Advisors Inc now owns 912 shares of the medical device company’s stock worth $209,000 after purchasing an additional 442 shares in the last quarter. 97.06% of the stock is currently owned by institutional investors.

Shares of COO stock opened at $274.50 on Thursday. The company has a current ratio of 2.58, a quick ratio of 1.54 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $13.41 billion, a P/E ratio of 24.15, a P/E/G ratio of 2.18 and a beta of 0.67. Cooper Companies Inc has a one year low of $216.47 and a one year high of $276.31.

Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Thursday, August 30th. The medical device company reported $3.00 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $3.07 by ($0.07). The company had revenue of $660.00 million during the quarter, compared to analyst estimates of $653.44 million. Cooper Companies had a net margin of 5.23% and a return on equity of 17.53%. research analysts expect that Cooper Companies Inc will post 11.62 earnings per share for the current fiscal year.

Several analysts have recently weighed in on the company. ValuEngine raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Thursday. TheStreet raised Cooper Companies from a “c+” rating to a “b-” rating in a report on Friday, June 15th. Zacks Investment Research raised Cooper Companies from a “sell” rating to a “hold” rating in a report on Monday. Oppenheimer set a $265.00 price objective on Cooper Companies and gave the stock a “hold” rating in a report on Friday, June 8th. Finally, Raymond James decreased their price objective on Cooper Companies from $275.00 to $270.00 and set an “outperform” rating on the stock in a report on Tuesday, June 5th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $274.11.

In related news, COO Daniel G. Mcbride sold 2,147 shares of the business’s stock in a transaction on Friday, June 29th. The stock was sold at an average price of $235.13, for a total value of $504,824.11. Following the sale, the chief operating officer now owns 28,395 shares of the company’s stock, valued at approximately $6,676,516.35. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director A Thomas Bender sold 7,150 shares of the business’s stock in a transaction on Monday, September 24th. The shares were sold at an average price of $269.36, for a total value of $1,925,924.00. Following the completion of the sale, the director now directly owns 18,355 shares in the company, valued at approximately $4,944,102.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 87,725 shares of company stock worth $22,318,098. 1.60% of the stock is owned by insiders.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

See Also: Short Selling

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.